OSTEOPOROSIS - IS 1,25-(OH)2D3 OF VALUE IN TREATMENT

被引:11
作者
BRAUTBAR, N
机构
关键词
D O I
10.1159/000183979
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:161 / 166
页数:6
相关论文
共 46 条
[1]   RISK-FACTORS FOR POSTMENOPAUSAL OSTEOPOROSIS [J].
ALOIA, JF ;
COHN, SH ;
VASWANI, A ;
YEH, JK ;
YUEN, K ;
ELLIS, K .
AMERICAN JOURNAL OF MEDICINE, 1985, 78 (01) :95-100
[2]  
AVIOLI LV, 1979, OSTEOPOROSIS, V2, P49
[3]  
Baylink D J, 1967, Clin Orthop Relat Res, V55, P51
[4]  
BERLYNE GM, 1975, Q J MED, V44, P505
[5]   THE HORMONAL FORM OF VITAMIN-D IN THE PATHO-PHYSIOLOGY AND THERAPY OF POSTMENOPAUSAL OSTEOPOROSIS [J].
CANIGGIA, A ;
NUTI, R ;
LORE, F ;
VATTIMO, A .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1984, 7 (04) :373-378
[6]   SERUM VITAMIN-D METABOLITES IN YOUNGER AND ELDERLY POSTMENOPAUSAL WOMEN [J].
CHRISTIANSEN, C ;
RODBRO, P .
CALCIFIED TISSUE INTERNATIONAL, 1984, 36 (01) :19-24
[7]   EFFECT OF 1,25-DIHYDROXY-VITAMIN-D3 IN ITSELF OR COMBINED WITH HORMONE-TREATMENT IN PREVENTING POST-MENOPAUSAL OSTEOPOROSIS [J].
CHRISTIANSEN, C ;
CHRISTENSEN, MS ;
RODBRO, P ;
HAGEN, C ;
TRANSBOL, I .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1981, 11 (04) :305-309
[8]   THE VITAMIN-D METABOLITES IN THE PATHOGENESIS AND MANAGEMENT OF OSTEOPOROSIS [J].
CRILLY, RG ;
HORSMAN, A ;
PEACOCK, M ;
NORDIN, BEC .
CURRENT MEDICAL RESEARCH AND OPINION, 1981, 7 (05) :337-348
[10]  
DELUCA HF, 1976, J LAB CLIN MED, V87, P7